Release Date: 16/03/18 15:47 Summary: Extension of Offer Period Price Sensitive: Yes Download Document 110.54KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%